{
     "PMID": "24703968",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20141224",
     "LR": "20140512",
     "IS": "1532-2785 (Electronic) 0143-4179 (Linking)",
     "VI": "48",
     "IP": "3",
     "DP": "2014 Jun",
     "TI": "Aminoguanidine treatment ameliorates inflammatory responses and memory impairment induced by amyloid-beta 25-35 injection in rats.",
     "PG": "153-9",
     "LID": "10.1016/j.npep.2014.03.002 [doi] S0143-4179(14)00030-4 [pii]",
     "AB": "Alzheimer disease (AD) is a neurodegenerative disorder caused by accumulation of the amyloid-beta peptide (Abeta) in neuritic plaques. Its neurotoxic mechanisms are associated with inflammatory responses and nitrosative stress generation that promote expression of inducible nitric oxide synthase (iNOS) and increased nitric oxide causing neuronal death and memory impairment. Studies suggest that treatment with anti-inflammatory and anti-oxidant agents decreases the risk of developing AD. Aminoguanidine (AG) is an iNOS inhibitor with anti-inflammatory and anti-oxidant effects. In this study, we evaluated the effects of systemic administration of AG (100 mg/kg/day for 4 days) on spatial memory and inflammatory responses induced by an injection of Abeta(25-35) [100 muM] into the temporal cortex (TCx) of rats. A significant improvement of spatial memory was evident in the Abeta(25-35)-treated group at day 30 post-injection subjected to AG treatment; this effect was correlated with decreases in reactive gliosis, IL-1beta, TNF-alpha, and nitrite levels, as well as a reduction in neurodegeneration in the TCx and hippocampus (Hp). These results suggest that AG treatment inhibited glia activation and cytokine release, which may help to counteract neurodegenerative events induced by the toxicity of Abeta.",
     "CI": [
          "Copyright (c) 2014 Elsevier Ltd. All rights reserved."
     ],
     "FAU": [
          "Diaz, Alfonso",
          "Rojas, Karla",
          "Espinosa, Blanca",
          "Chavez, Raul",
          "Zenteno, Edgar",
          "Limon, Daniel",
          "Guevara, Jorge"
     ],
     "AU": [
          "Diaz A",
          "Rojas K",
          "Espinosa B",
          "Chavez R",
          "Zenteno E",
          "Limon D",
          "Guevara J"
     ],
     "AD": "Facultad de Ciencias Quimicas, BUAP, Puebla, PL, Mexico; Laboratorio Experimental de Enfermedades Neurodegenerativas, INNN-MVS, Mexico, DF, Mexico; Departamento de Bioquimica, Facultad de Medicina, UNAM, Mexico, DF, Mexico. Laboratorio Experimental de Enfermedades Neurodegenerativas, INNN-MVS, Mexico, DF, Mexico. Laboratorio de Bioquimica, INER-ICV, Mexico, DF, Mexico. Departamento de Bioquimica, Facultad de Medicina, UNAM, Mexico, DF, Mexico. Departamento de Bioquimica, Facultad de Medicina, UNAM, Mexico, DF, Mexico. Facultad de Ciencias Quimicas, BUAP, Puebla, PL, Mexico. Departamento de Bioquimica, Facultad de Medicina, UNAM, Mexico, DF, Mexico. Electronic address: Jorge.Guevara@comunidad.unam.mx.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20140324",
     "PL": "Netherlands",
     "TA": "Neuropeptides",
     "JT": "Neuropeptides",
     "JID": "8103156",
     "RN": [
          "0 (Amyloid beta-Peptides)",
          "0 (Guanidines)",
          "0 (Peptide Fragments)",
          "0 (amyloid beta-protein (25-35))",
          "EC 1.14.13.39 (Nitric Oxide Synthase Type II)",
          "SCQ4EZQ113 (pimagedine)"
     ],
     "SB": "IM",
     "MH": [
          "Alzheimer Disease/*drug therapy",
          "Amyloid beta-Peptides/toxicity",
          "Animals",
          "Guanidines/pharmacology/*therapeutic use",
          "Inflammation/drug therapy",
          "Male",
          "Memory Disorders/chemically induced/*drug therapy",
          "Nitric Oxide Synthase Type II/*antagonists & inhibitors",
          "Peptide Fragments/toxicity",
          "Rats",
          "Rats, Wistar",
          "Spatial Memory/drug effects",
          "Temporal Lobe/drug effects/metabolism"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Alzheimer disease",
          "IL-1beta",
          "Neuroprotection",
          "Nitric oxide",
          "Spatial memory",
          "iNOS"
     ],
     "EDAT": "2014/04/08 06:00",
     "MHDA": "2014/12/30 06:00",
     "CRDT": [
          "2014/04/08 06:00"
     ],
     "PHST": [
          "2013/11/20 00:00 [received]",
          "2014/02/18 00:00 [revised]",
          "2014/03/14 00:00 [accepted]",
          "2014/04/08 06:00 [entrez]",
          "2014/04/08 06:00 [pubmed]",
          "2014/12/30 06:00 [medline]"
     ],
     "AID": [
          "S0143-4179(14)00030-4 [pii]",
          "10.1016/j.npep.2014.03.002 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Neuropeptides. 2014 Jun;48(3):153-9. doi: 10.1016/j.npep.2014.03.002. Epub 2014 Mar 24.",
     "term": "hippocampus"
}